By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Almirall Prodesfarma, S.A. 

General Mitre, 151

Barcelona    08022  Spain
Phone: 34-932-913-000 Fax: 34-932-913-180




Company News
Almirall Prodesfarma Key Drug Trials Disappoint Investors 9/3/2008 6:38:02 AM
Almirall Prodesfarma and Proteros biostructures GmbH Announce Successful Achievement of Key Scientific Milestone in Structural Biology Collaboration 7/24/2008 8:58:40 AM
Forest Laboratories, Inc. (FRX) and Almirall Announce Positive Results of Clinical Studies for Aclidinium Bromide, a Novel, Long-Acting Anticholinergic for the Treatment for COPD 5/21/2008 7:44:43 AM
Shire Pharmaceuticals Group plc (SHPGY) Sells Medicines to Almirall Prodesfarma for $213 Million 10/8/2007 6:23:10 AM
Sareum Ltd. (SAR.L) Release: Extension Of Collaboration With Almirall Prodesfarma 7/13/2006 4:52:41 PM
Forest Laboratories, Inc. (FRX) And Almirall Announce A Development And Marketing Collaboration Agreement On New Therapy For COPD 4/10/2006 11:19:29 AM
Neurocrine Biosciences, Inc. (NBIX) Announces Licensing Agreement With Almirall Prodesfarma For Parkinson's Disease10/19/2005 5:12:09 PM
Evotec Enters Into Long-Term Focused Library Agreement With Evotec OAI (United Kingdom)10/19/2005 5:11:57 PM
Dainippon Pharmaceutical , Meiji Seika Kaisha, Ltd. Jointly Market New Formulations For Ebastel Antiallergic Agent10/19/2005 5:09:29 PM